SAP Balances Nayara Support Order Against Cloud Momentum and a Fresh JPMorgan Upgrade

SAP's Indian arm must keep providing software support to Nayara Energy while its appeal runs on, after the Delhi High Court on 5 November declined to suspend an earlier order requiring the support to resume. The ruling leaves a binding legal obligation in place alongside the company's newer cloud ambitions — a pairing that gives investors two very different yardsticks to watch.

The appeal itself is still live. Media reports put the next hearing on 11 January 2027, which means a court date lands ahead of SAP's preliminary annual results. Anyone weighing the stock therefore needs to track both the rollout of the cloud business and how the Nayara dispute unfolds.

Execution, not announcements, is the operative test

The clearest operational gauge is whether announced cloud projects actually get delivered. A constructive read depends on customer decisions turning into implemented systems: choosing or agreeing to a solution is only the starting point, and what matters afterward is how far the deployment progresses.

SAP said yesterday that AstraZeneca is moving to SAP Cloud ERP Private under RISE with SAP, while also evaluating Business AI capabilities. The step extends a partnership that has run for 20 years. The two elements carry different weight — the migration is a firm customer decision, whereas the AI functions remain under review. Extra support for growth expectations would only emerge if that review leads to actual use, so customer execution stays the benchmark rather than the mere prospect of more AI applications.

A second data point comes from the Dutch defence ministry. On 4 November, SAP and the ministry agreed to develop and operate a sovereign cloud environment in the Netherlands, with the start scheduled for 1 January 2028. Should development and go-live proceed as planned, the project could reinforce the outlook. Together with the AstraZeneca migration, it offers tangible work against which the cloud strategy can be judged — and progress on those fronts would tell investors more than broadly worded growth hopes.

Should investors sell immediately? Or is it worth buying SAP?

JPMorgan turns bullish on the pilot-to-production shift

On Monday, JPMorgan upgraded SAP from Neutral to Overweight and lifted its price target from €175 to €275. Analyst Toby Ogg tied the re-rating to enterprise AI moving out of pilot projects and into production, and also pointed to the potential of integrated enterprise data. Further live deployments would underpin that view. At AstraZeneca, the added AI contribution hinges on how the evaluation of the functions turns out and what steps follow.

Security and buyback round out the picture

SAP also held its Security Patch Day yesterday, publishing 35 new security notes and updating three existing ones. Among the fixed vulnerabilities, according to the company, were flaws rated critical with a CVSS score of 10.0. SAP issued four GitHub security advisories as well, so the release covered both fresh disclosures and updates to previously issued information.

On the capital-return side, SAP reported buying roughly 465,000 of its own shares in the past week, at an aggregate volume of about €95.4 million. By the end of last week, the programme had repurchased a total of around 9.6 million shares.

Two dates to diarise

The legal risk is already live rather than hypothetical: SAP India must continue supporting Nayara Energy throughout the appeal, and relief would require the relevant court order to change. The less favourable scenario would be a prolonged legal obligation combined with slower cloud progress, leaving concrete commitments standing against expectations for new applications — a case for caution especially if customer projects slip.

The AstraZeneca comparison highlights the differing time horizons. There, the focus is a migration plus the evaluation of additional functions; in the Nayara case, a court mandate already applies. Investors should therefore weigh future business opportunities and existing obligations according to their actual status.

As long as cloud projects advance on schedule and the support dispute does not escalate, the positive case remains tied to concrete customer work. Should deployments stall or the proceedings turn unfavourable, a more cautious assessment of expectations would be reasonable. The next fixed point is the 11 January 2027 hearing. SAP then publishes its preliminary results for the fourth quarter and full-year 2026 on 28 January 2027 at 6:00 CET, with an analyst and investor conference scheduled for 07:00 CET that day. That sequence gives shareholders two distinct tests — first the court's direction, then the numbers.

Ad

SAP Stock: New Analysis - 11 November

Fresh SAP information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated SAP analysis...